Re: MKT Message and otherwise
I think the biotech sector should be in a great position going forward after the ACA was shelved, seems to me that biotech will get all of the benefits of faster FDA approvals and perhaps lower rate tax repatriation without the specter of drug pricing reform hanging over head. As I said on the Exel board, Biotech has already undergone a correction since 2015, it looks like the place to be going forward. I expect the turbulence in the market to smooth out quickly. I'm trying to focus on the positives, hoping my PRTK can hold it's pre-market gains today. Good Luck!